Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy.

PURPOSE: To evaluate long-term risk and outcomes of glaucoma in eyes with intermediate, posterior, and panuveitis managed with systemic or fluocinolone acetonide (0.59 mg, “implant”) therapy. DESIGN: Prospective Follow-up of the Multicenter Uveitis Steroid Treatment (MUST) Clinical Trial Cohort METH...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Ophthalmol
Autores principales: Kempen, John H., Van Natta, Mark L., Friedman, David S., Altaweel, Michael M., Ansari, Husam, Dunn, James P., Elner, Susan G., Holbrook, Janet T., Lim, Lyndell L., Sugar, Elizabeth A., Jabs, Douglas A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606748/
https://ncbi.nlm.nih.gov/pubmed/32628922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2020.06.038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares